Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF548 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DCSTAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKIRAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WASL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COLQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEBL-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BFSP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHRS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPRC5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYH11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on